Breaking News Instant updates and real-time market news.

HIMX

Himax

$8.59

0.16 (1.90%)

, TZA

Small Cap Bear 3x

$26.87

-0.85 (-3.07%)

08:45
10/03/16
10/03
08:45
10/03/16
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Himax Technologies (HIMX) 5.97% +1.44, Direxion Daily Small Cap Bear 3X Shares (TZA) 4.77% +0.78, First Solar (FSLR) 1.20% +0.67, Sprint (S) 1.11% +0.36, Fitbit (FIT) 2.31% +0.33, Deutsche Bank (DB) 1.49% +0.31, Goodyear (GT) 0.55% +0.30, Fiat Chrysler (FCAU) 2.40% +0.21, ProShares Ultra DJ UBS Crude Oil (UCO) 2.30% +0.20, and Gap (GPS) 0.93% +0.19.

HIMX

Himax

$8.59

0.16 (1.90%)

TZA

Small Cap Bear 3x

$26.87

-0.85 (-3.07%)

FSLR

First Solar

$39.49

0.41 (1.05%)

S

Sprint

$6.63

-0.03 (-0.45%)

FIT

Fitbit

$14.84

0.02 (0.13%)

DB

Deutsche Bank

$13.09

1.61 (14.02%)

GT

Goodyear Tire

$32.30

0.57 (1.80%)

FCAU

Fiat Chrysler

$6.40

0.26 (4.23%)

UCO

Universal Compression

$10.38

0.13 (1.27%)

GPS

Gap

$22.24

0.54 (2.49%)

  • 23

    Oct

  • 25

    Oct

  • 01

    Nov

  • 08

    Dec

HIMX Himax
$8.59

0.16 (1.90%)

09/02/16
NOMU
09/02/16
NO CHANGE
Target $12
NOMU
Buy
Himax price target raised to $12 on better pricing at Nomura
Nomura analyst Donnie Teng noted that Himax has been able to raise its prices for its liquid crystal on silicon, or LCOS, and wafer level optics, or WLO, for a major augmented reality device recently, which he believes could help the company reach the higher end of its Q3 sales guidance. Teng raised his price target on Himax shares to $12 from $9.70, adding that the company plans to try to provide more cost effective LCOS and WLO products for a possible consumer AR device in 2018, which lead to higher demand. Nomura keeps a Buy rating on the stock.
09/26/16
NOMU
09/26/16
DOWNGRADE
NOMU
Neutral
Himax downgraded to Neutral from Buy at Nomura
09/28/16
ROTH
09/28/16
INITIATION
Target $10
ROTH
Buy
Himax initiated with a Buy at Roth Capital
Roth Capital analyst Suji Desilva initiated Himax with a Buy and a $10 price target. Desilva believes newer HIMX products can participate in growth of IoT device categories such as augmented reality and virtual reality head-mounted devices.
09/29/16
FBCO
09/29/16
NO CHANGE
FBCO
Outperform
Himax long-term story intact, says Credit Suisse
Credit Suisse analyst Jerry Su lowered Himax's LCOS/WLO shipment assumptions for Q4-1H 2017 on slower new platform adoption following supply chain checks. Su said the 2018 AR device ramp is on track and believes Himax's long-term story on consumer AR glass and 3D sensing for smartphone remains intact, since the capacity ramp up remains on schedule. The analyst said the potential launch of consumer AR glass and 3D sensing for smartphone should boost Himax's earnings in 2018 and reiterates his Outperform rating and $14 price target.
TZA Small Cap Bear 3x
$26.87

-0.85 (-3.07%)

FSLR First Solar
$39.49

0.41 (1.05%)

09/08/16
09/08/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with an Underperform, $160 target at Cowen with analyst Jeffrey Osborne saying the company is well positioned for the long term but has a "material amount of execution risk" over the next 12 to 18 months. 2. AutoNation (AN) initiated with a Buy at CL King. 3. Wingstop (WING) initiated with an Overweight at KeyBanc. 4. Vivint Solar (VSLR), Sunrun (RUN), and SolarEdge (SEDG) initiated with an Outperform at JMP Securities with the firm initiated First Solar (FSLR) and SunPower (SPWR) with an Underperform. The firm also initiated Canadian Solar (CSIQ) with a Market Perform. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/30/16
09/30/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN) initiated with a Buy at Guggenheim. 2. Wal-Mart (WMT) initiated with an Overweight at KeyBanc and a Buy at Guggenheim. 3. Harley-Davidson (HOG) initiated with a Hold at Jefferies. 4. Coach (COH) was initiated with a Buy at Guggenheim while the firm initiated Michael Kors (KORS) with a Neutral. 5. First Solar (FSLR) initiated with a Buy at Williams Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/30/16
WILL
09/30/16
INITIATION
Target $50
WILL
Buy
First Solar initiated with a Buy at Williams Capital
Williams Capital analyst Cynthia Motz initiated First Solar with a Buy and a $50 price target.
09/30/16
ROTH
09/30/16
NO CHANGE
ROTH
Possible Chinese tariff cuts a negative for solar names, says Roth Capital
Roth Capital analyst Philip Shen noted media reports in China indicating that certain solar feed-in tariff levels may be cut by 23-52%, depending on region and project type, in January 2017. While there appears to be some confusion on which projects may qualify for the 2016 tariff ahead of the 2017 FIT stepdown, Shen tells investors that he sees the reports on the whole as more negative news for the industry. Publicly traded companies in the solar space include Canadian Solar (CSIQ), First Solar (FSLR), JA Solar (JASO), SolarCity (SCTY), SunEdison (SUNEQ), SunPower (SPWR), Trina Solar (TSL) and Yingli Green Energy (YGE).
S Sprint
$6.63

-0.03 (-0.45%)

09/15/16
FBCO
09/15/16
NO CHANGE
Target $150
FBCO
Outperform
Credit Suisse raises Apple iPhone estimates on survey, carrier comments
Credit Suisse analyst Kulbinder Garcha said that build plans noted by the firm's tech team in Japan, the firm's proprietary iPhone survey and recent announcements from Sprint (S) and T-Mobile (TMUS) all lead him to now believe that Apple's (AAPL) iPhone 7 cycle may be stronger than anticipated. Accordingly, Garcha increased his calendar year 2016 iPhone volume estimate to 215M from 208M and took his calendar year 2017 estimate up to 221M units from 217M units. Additionally, two recent surveys conducted by the firm point to a potential beneficial mix shift, as more buyers appear to be shifting toward the Plus model compared to the mix in the iPhone 6s cycle, Garcha tells investors. The analyst reiterates an Outperform rating and $150 price target on Apple shares, which closed yesterday at $111.77.
09/12/16
DBAB
09/12/16
DOWNGRADE
DBAB
Hold
SoftBank downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Peter Milliken downgraded Softbank (SFTBY) to Hold saying the company's rebuilding efforts should take time. The analyst expects the stock to trade largely in line with Alibaba (BABA), Sprint (S) and the yen over the next 12 months, and he feels much of the upside has already been realized in the first two.
09/13/16
WELS
09/13/16
NO CHANGE
WELS
Market Perform
Apple iPhone 7 strength consistent with view, says Wells Fargo
Wells Fargo analyst Maynard Um says the iPhone 7 pre-order strength announced by T-Mobile (TMUS) and Sprint (S) is consistent with his view that "aggressive carrier promotions" should help to drive sales of the next generation phone. Um still expects Apple's multiple expansion to be limited given the "limited visibility and some concern into the March quarter." The analyst keeps a Market Perform rating on Apple shares with a $105-$120 price target range.
09/20/16
PIPR
09/20/16
NO CHANGE
PIPR
Overweight
Piper survey shows decline in iPhone upgrade interest
Piper Jaffray analyst Gene Munster says his firm's survey of 403 U.S. iPhone owners suggests that interest in an iPhone 7 upgrade declined after the announcement of the device. The data contradicts "generally positive" initial demand indicators including from carriers including T-Mobile (TMUS) and Sprint (S), Munster tells investors in a research note. The analyst questions iPhone 7 demand into Apple's (AAPL) March and June quarters but remains confident in his thinking for flattish growth for iPhone 7 versus iPhone 6. Munster reiterates an Overweight rating on Apple.
FIT Fitbit
$14.84

0.02 (0.13%)

09/29/16
MZHO
09/29/16
NO CHANGE
MZHO
Fitbit Charge 2 checks remain strong, pullback unwarranted, says Mizuho
Mizuho's checks indicate Fitbit's Charge 2 sell through remains strong with favorable reviews, despite investor concerns. The firm's analyst views the pullback in Fitbit shares as unwarranted, especially since Q3 guidance assume minimal unit sales, and expects the Charge 2 to compete well and serve as a catalyst for Holiday season into Spring 2017. Mizuho continues to believe in Fitbit's long-term opportunity to maintain dominant share with in the increasingly growing global market for wearables while pursing opportunities in the healthcare industry.
09/29/16
MZHO
09/29/16
NO CHANGE
MZHO
Fitbit shares defended at Mizuho
09/29/16
PACS
09/29/16
DOWNGRADE
PACS
Underweight
Pacific Crest cuts Fitbit to sell, sees share downside to $11
Pacific Crest analyst Brad Erickson downgraded Fitbit (FIT) to Underweight from Sector Weight after his channel checks indicated that Charge 2, the company's flagship holiday product, is off to a slow start. Underweight is Pacific Crest's equivalent of a sell rating. Charge 2 inventory is accumulating in the channel and sell-through is below initial Blaze/Alta levels, Erickson tells investors in a research note. The analyst continues to believe that a large portion of Fitbit owners stop using the device within months. Further, he views the corporate wellness deal between Aetna (AET) and Apple (AAPL) as a "substantial negative" for Fitbit. Erickson sees downside to $11 for shares of Fitbit. The stock closed yesterday up 17c to $16.70.
09/29/16
09/29/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Coca-Cola (KO) downgraded to Hold from Buy at Stifel with analyst Mark Swartzberg saying that Coca-Cola's and Pepsi's organic EPS growth appears to be similar, but he believes that Pepsi is less vulnerable to foreign exchange fluctuations. 2. Fitbit (FIT) downgraded to Underweight from Sector Weight at Pacific Crest analyst Brad Erickson citing his channel checks which indicated that Charge 2, the company's flagship holiday product, is off to a slow start. 3. Discovery (DISCA) downgraded to Market Perform from Outperform at Barrington with analyst James Goss saying that Brexit and sports costs are dragging on its international results and foreign exchange tailwinds are moderating in many geographies. 4. Sonus (SONS) downgraded to Underperform from Market Perform at Cowen with analyst Paul Silverstein saying the firm's industry checks uncovered operational challenges and ongoing employee and executive churn. 5. Alcobra (ADHD) downgraded to Hold from Buy at Cantor and to Perform from Outperform at Oppenheimer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
DB Deutsche Bank
$13.09

1.61 (14.02%)

09/29/16
COWN
09/29/16
NO CHANGE
COWN
DoJ will not destabilize Deutsche Bank, says Cowen
Cowen analyst Jaret Seiberg sees little practical or political upside for the Justice Department to press Deutsche Bank for a penalty that is so large it could destabilize the bank and create a new financial crisis. He expects the penalty for violations related to mortgage-backed securities to be structured below the speculated $14B that seems to have alarmed the market. Seiberg adds both sides have incentives to reach a deal quickly.
09/19/16
09/19/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DSW (DSW) initiated with a Negative at Susquehanna. 2. Deutsche Bank (DB) initiated with an Underperform at Credit Suisse. 3. UBS (UBS) initiated with a Neutral at Credit Suisse. 4. Cerner (CERN) initiated with a Neutral at BofA/Merrill. 5. Callidus Software (CALD) reinstated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/16
FBCO
09/19/16
INITIATION
FBCO
Underperform
Deutsche Bank initiated with an Underperform at Credit Suisse
Credit Suisse analyst Jon Peace initiated Deutsche Bank with an Underperform saying the recent slow filing and capital shortfall will lower dividend expectations and keep shares under pressure.
09/30/16
09/30/16
NO CHANGE

Correction: Deutsche Bank credit upgraded to Neutral at BofA/Merrill
BofA/Merrill upgraded Deutsche Bank's credit to Neutral, not the equity.
GT Goodyear Tire
$32.30

0.57 (1.80%)

09/06/16
DBAB
09/06/16
UPGRADE
Target $37
DBAB
Buy
Goodyear Tire upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Rod Lache upgraded Goodyear Tire to Buy saying the company should be able to generate "significant" free cash flow now that its balance sheet repair is largely complete. The analyst expects most of the cash flow to be returned to investors. He raised his price target for Goodyear shares to $37 from $29.
04/07/16
04/07/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Barnes Group (B) upgraded to Buy at Deutsche Bank by analyst Myles Walton, who said the current valuation is "compelling" given the company's "positive" future growth prospects. 2. Brocade (BRCD) upgraded to Buy at Argus with analyst Jim Kelleher citing compelling valuation following the selloff on deal news, as well as the company's evolving strategy to move its business towards next-generation data center. 3. Coach (COH) upgraded to Outperform at William Blair by analyst Amy Noblin, who said store checks and her firm's Spring 2016 Handbag Survey bring greater confidence in an inflection point in the business. 4. Wynn Resorts (WYNN) upgraded to Outperform at Telsey Advisory by analyst David Katz who cited the stronger than expected outlook provided by the company. He added that historical execution supports confidence in management to achieve at least the bottom end of guidance. 5. Cooper Tire (CTB) and Goodyear Tire (GT) upgraded to Overweight at KeyBanc citing a positive North American volume outlook and continued stable pricing. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/20/16
STPT
05/20/16
UPGRADE
STPT
Buy
Goodyear Tire upgraded to Buy from Hold at Standpoint Research
05/02/16
ARGS
05/02/16
NO CHANGE
ARGS
Goodyear Tire weakness overdone, says Argus
After Goodyear reported higher than expected EPS but lower than expected revenue, Argus still expects the company's profits to rise this year. The firm says that the stock's valuation is attractive, and it thinks the weakness in the stock creates a favorable entry point.
FCAU Fiat Chrysler
$6.40

0.26 (4.23%)

08/09/16
JEFF
08/09/16
INITIATION
Target $8.25
JEFF
Buy
Fiat Chrysler initiated with a Buy at Jefferies
Jefferies analyst Philippe Houchois started Fiat Chrysler with a Buy rating and $8.25 price target.
08/09/16
08/09/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ford (F) initiated with an Underperform, General Motors (GM) initiated with a Hold, and Fiat Chrysler (FCAU) initiated with a Buy at Jefferies. Ford and General Motors were also initiated with a Buy at Seaport Global. 2. AMC Networks (AMCX) initiated with a Hold at Loop Capital. 3. Lionsgate (LGF) initiated with a Buy at Loop Capital. 4. Barrick Gold (ABX) initiated with an Equal Weight at Morgan Stanley. 5. AdvancePierre Foods (APFH) initiated with a Neutral at Goldman, an Outperform at BMO Capital, a Buy at Deutsche Bank, and an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/06/16
LEHM
07/06/16
DOWNGRADE
LEHM
Underweight
Fiat Chrysler downgraded to Underweight from Overweight at Barclays
Barclays analyst Kristina Church double downgraded Fiat Chrysler to Underweight from Overweight and cut her price target for the shares to EUR 5.5 from EUR 10. The company's "highly levered" balance sheet makes it "too risky to own," Church tells investors in a research note.
07/06/16
07/06/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Netflix (NFLX) downgraded to Underperform from Hold at Jefferies with analyst John Janedis saying Netflix's domestic subscriber growth trajectory "may be somewhat flatter" than the market's current expectations. 2. American Airlines (AAL) downgraded to Underperform from Outperform at Credit Suisse with analyst Jule Yates downgrading the airline two notches citing high leverage, weaker free cash flow, and a lofty valuation. 3. AB InBev (BUD) downgraded to Underperform from Sector Perform at RBC Capital with analyst James Edwardes Jones saying he expects normal synergies from the SABMiller (SBMRY) deal but said it will not materially alter AB InBev's volume concentration and lacks additional upside. 4. Fiat Chrysler (FCAU) downgraded to Underweight from Overweight at Barclays with analyst Kristina Church downgrading the stock two notches saying, the company's "highly levered" balance sheet makes it "too risky to own." 5. United Continental (UAL) downgraded to Neutral from Outperform at Credit Suisse with analyst Jule Yates citing challenging revenue growth heading into Q3. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
UCO Universal Compression
$10.38

0.13 (1.27%)

GPS Gap
$22.24

0.54 (2.49%)

08/19/16
MSCO
08/19/16
NO CHANGE
Target $21
MSCO
Underweight
Gap valuation stretched adn upside limited, says Morgan Stanley
Morgan Stanley analyst Kimberly Greenberger said Gap's valuation appears stretched and upside is limited. The analyst said even the most bullish expectations for $2.25-$2.30 in 2017 implies zero earnings growth since 2012, with less scope for cuts in marketing expense, wage inflation, and other SG&A inflation. Greenberger has an Underweight rating on Gap and a $21 price target on shares.
07/25/16
STPT
07/25/16
DOWNGRADE
STPT
Hold
Gap downgraded to Hold from Buy at Standpoint Research
08/09/16
MZHO
08/09/16
UPGRADE
MZHO
Neutral
Gap upgraded to Neutral from Underperform at Mizuho
08/19/16
JEFF
08/19/16
NO CHANGE
Target $30
JEFF
Buy
Gap price target raised to $30 from $26 at Jefferies
Jefferies analyst Randal Konik raised his price target for Gap to $30 saying the company's Q2 results "point to trends moving in the right direction." The analyst views the shares as attractive at current levels and reiterates a Buy rating on the name.

TODAY'S FREE FLY STORIES

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.